Editorial commentary: Viridans group streptococci in febrile neutropenic cancer patients: What should we fear?

Alison G. Freifeld, Raymund R. Razonable

Research output: Contribution to journal › Comment/debate › peer-review

13 Scopus citations

Fingerprint

Dive into the research topics of 'Editorial commentary: Viridans group streptococci in febrile neutropenic cancer patients: What should we fear?'. Together they form a unique fingerprint.